🇺🇸 FDA
Patent

US 7442806

Processes for preparing darifenacin hydrobromide

granted A61PA61P13/00

Quick answer

US patent 7442806 (Processes for preparing darifenacin hydrobromide) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P13/00